Structure-Based Design and Synthesis ofNω-Nitro-l-Arginine-Containing Peptidomimetics as Selective Inhibitors of Neuronal Nitric Oxide Synthase. Displacement of the Heme Structural Water
- 11 April 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (9), 2089-2099
- https://doi.org/10.1021/jm061305c
Abstract
The neuronal isoform of nitric oxide synthase (nNOS), the enzyme responsible for the production of nitric oxide in the central nervous system, represents an attractive target for the treatment of various neurodegenerative disorders. X-ray crystal structures of complexes of nNOS with two nNOS-selective inhibitors, (4S)-N-{4-amino-5-[(2-aminoethylamino]pentyl}-N‘-nitroguanidine (1) and 4-N-(Nω-nitro-l-argininyl)-trans-4-amino-l-proline amide (2), led to the discovery of a conserved structural water molecule that was hydrogen bonded between the two heme propionates and the inhibitors (Figure 2). On the basis of this observation, we hypothesized that by attaching a hydrogen bond donor group to the amide nitrogen of 2 or to the secondary amine nitrogen of 1, the inhibitor molecules could displace the structural water molecule and obtain a direct interaction with the heme cofactor. To test this hypothesis, peptidomimetic analogues 3 − 5, which have either an N-hydroxyl (3 and 5) or N-amino (4) donor group, were designed and synthesized. X-ray crystal structures of nNOS with inhibitors 3 and 5 bound verified that the N-hydroxyl group had, indeed, displaced the structural water molecule and provided a direct interaction with the heme propionate moiety (Figures 5 and 6). Surprisingly, in vitro activity assay results indicated that the addition of a hydroxyl group (3) only increased the potency slightly against the neuronal isoform over the parent compound (1). Rationalizations for the small increase in potency are consistent with other changes in the crystal structures.Keywords
This publication has 74 references indexed in Scilit:
- Guanylate cyclase and the ⋅NO/cGMP signaling pathwayBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1999
- INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGETAnnual Review of Pharmacology and Toxicology, 1999
- Arrays with Local Centers of Symmetry in Space Groups Pca21 and Pna21Acta crystallographica Section B, Structural science, crystal engineering and materials, 1998
- Soluble guanylate cyclase: the forgotten siblingTrends in Pharmacological Sciences, 1997
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- The Entropic Cost of Bound Water in Crystals and BiomoleculesScience, 1994
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- Near-coincidence orientations in hexagonal materials: from a unified twin approach to a quasiperiodic descriptionActa Crystallographica Section A Foundations of Crystallography, 1991
- Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems.Irwin H. SegelThe Quarterly Review of Biology, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973